Ebola Patient Released from Hospital in Rome

Italy's only Ebola patient is fully recovered and was released from hospital on Friday more than a month after being flown to Rome from Sierra Leone where he worked as a doctor treating others

Join Our Community of Science Lovers!

By Steve Scherer

ROME (Reuters) - Italy's only Ebola patient is fully recovered and was released from hospital on Friday more than a month after being flown to Rome from Sierra Leone where he worked as a doctor treating others stricken by the disease.

The 50-year-old Sicilian man has been identified only by his first name, Fabrizio. He contracted the hemorrhagic virus while working for humanitarian group Emergency during the worst Ebola outbreak on record.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

"For the first few days, partly to keep my mind active, I tried to examine every symptom I was experiencing scientifically," Fabrizio told reporters in his first public appearance since contracting the disease.

"Then there came a moment when I lost consciousness of what was going on around me and I don't remember anything that happened for about two weeks," he said, thanking those who cared for him during his illness.

He said that after he regains his strength he may return to Sierra Leone to continue treating Ebola patients. Ebola survivors are generally believed to be immune to future infection from the strain that made them sick.

His blood, which contains antibodies that fight the virus, will be sent to Sierra Leone to help in treatment, a doctor who treated Fabrizio at the Lazzaro Spallanzani hospital said.

The virus is still spreading in West Africa, especially in Sierra Leone, and the number of known cases globally has exceeded 20,000, with 7,905 dead, the World Health Organization (WHO) said on Wednesday.

After his arrival in Rome on Nov. 25, the patient's condition worsened and he was moved to intensive care on Dec. 5, where he received respiratory assistance.

He was treated with a combination of an experimental drug never used before in Italy, and plasma taken from survivors of the disease.

(Writing by Steve Scherer; Editing by Toby Chopra)

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American